| Answer | Ultrarapid metabolizer | LA10315-2 |
| Answer | Rapid metabolizer | LA25390-8 |
| Answer | Normal metabolizer | LA25391-6 |
| Answer | Intermediate metabolizer | LA10317-8 |
| Answer | Poor metabolizer | LA9657-3 |
| answers-for | NAT2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 101143-6 |
| answers-for | Gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 51971-0 |
| answers-for | Genetic variation's effect on drug metabolism | 53040-2 |
| answers-for | UGT2B15 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 72878-2 |
| answers-for | TPMT gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 79713-4 |
| answers-for | CYP2C19 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 79714-2 |
| answers-for | CYP2D6 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 79715-9 |
| answers-for | CYP2C9 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 79716-7 |
| answers-for | CYP3A5 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 79717-5 |
| answers-for | UGT1A1 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 79718-3 |
| answers-for | DPYD gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 79719-1 |
| answers-for | CYP2B6 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 79720-9 |
| answers-for | CYP4F2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 79721-7 |
| answers-for | CYP3A4 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 81145-5 |
| answers-for | NUDT15 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 93195-6 |
| answers-for | COMT gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 93411-7 |
| answers-for | CYP1A2 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics method | 94254-0 |
| LONG_COMMON_NAME | en-US | [CPIC metab act] Ultrarapid|Rapid|Nl|Interm|Poor |
LOINC Version: 2.77
FHIR